Cartesian Therapeutics
RNAC
RNAC
54 hedge funds and large institutions have $28M invested in Cartesian Therapeutics in 2018 Q4 according to their latest regulatory filings, with 5 funds opening new positions, 26 increasing their positions, 16 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less funds holding in top 10
Funds holding in top 10: →
69% less first-time investments, than exits
New positions opened: 5 | Existing positions closed: 16
84% less capital invested
Capital invested by funds: $178M → $28M (-$150M)
90% less call options, than puts
Call options by funds: $1K | Put options by funds: $10K
Holders
54
Holding in Top 10
1
Calls
$1K
Puts
$10K
Top Buyers
| 1 | +$737K | |
| 2 | +$531K | |
| 3 | +$339K | |
| 4 |
Renaissance Technologies
New York
|
+$263K |
| 5 |
Two Sigma Investments
New York
|
+$249K |
Top Sellers
| 1 | -$2.22M | |
| 2 | -$2.1M | |
| 3 | -$1.01M | |
| 4 |
SSA
Schonfeld Strategic Advisors
New York
|
-$933K |
| 5 |
PVI
Pura Vida Investments
New York
|
-$905K |